Oral EBV-associated diffuse large B-cell lymphomas in HIV-negative immunocompromised patients;Orale Epstein-Barr-Virus-assoziierte diffuse grßzellige B-Zell-Lymphome bei HIV-negativen immunsupprimierten Patienten

Mund - Kiefer - und Gesichtschirurgie

Volumn 10, Issue 3, 2006, Pages 155-161

  Rhinow, K ^a   Schirmer, I ^a   Loddenkemper, C ^a   Anagnostopoulos, I ^a   Stein, H ^a   Reichart, Peter A ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

Diffuse large B cell lymphoma; Epstein Barr virus; Immunosuppression; Myasthenia gravis; Non Hodgkin's lymphoma

Indexed keywords

IMMUNOSUPPRESSIVE AGENT;

ADULT; ARTICLE; B CELL LYMPHOMA; CANCER STAGING; CASE REPORT; DIFFERENTIAL DIAGNOSIS; EPSTEIN BARR VIRUS INFECTION; FEMALE; HUMAN; JAW; LARGE CELL LYMPHOMA; MALE; MAXILLA TUMOR; MIDDLE AGED; NECROSIS; OPPORTUNISTIC INFECTION; PATHOLOGY; PERIODONTITIS; SERODIAGNOSIS; VIRUS INFECTION;

ADULT; ALVEOLAR PROCESS; DIAGNOSIS, DIFFERENTIAL; EPSTEIN-BARR VIRUS INFECTIONS; FEMALE; HIV SERONEGATIVITY; HUMANS; IMMUNOSUPPRESSIVE AGENTS; LYMPHOMA, B-CELL; LYMPHOMA, LARGE B-CELL, DIFFUSE; LYMPHOMA, LARGE-CELL, DIFFUSE; MALE; MAXILLARY NEOPLASMS; MIDDLE AGED; NECROSIS; NEOPLASM STAGING; OPPORTUNISTIC INFECTIONS; PERIODONTITIS;

EID: 33646424668     PISSN: 14329417     EISSN: 14343940     Source Type: Journal    
DOI: 10.1007/s10006-006-0689-x     Document Type: Article

References (24)

1. Anagnostopoulos I, Stein H (2000) Groβzellige B-Zell-Lymphome. Pathologe 21: 178-189
2. Angiero F, Stefani M, Crippa R (2006) Primary non-Hodgkin's lymphoma of the mandibular gingiva with maxillary gingival recurrence. Oral Oncol Extra (in press)
3. Armitage JO (2005) Staging non-Hodgkin lymphoma. CA Cancer J Clin 55: 368-376
4. Carbone PP, Kaplan HS, Musshoff K et al. (1971) Report of the Committee on Hodgkin's Disease Staging Classification. Cancer Res 31: 1860-1861
5. Coiffier B, Lepage E, Briere J et al. (2002) CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma. N Engl J Med 346: 235-242
6. Delecluse HJ, Anagnostopoulos I, Dallenbach F et al. (1997) Plasmablastic lymphomas of the oral cavity: A new entity associated with the human immunodeficiency virus infection. Blood 89: 1413-1420
7. Epstein JB, Epstein JD, Le ND, Gorsky M (2001) Characteristics of oral and paraoral malignant lymphoma: A population-based review of 361 cases. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 92: 519-525
8. Faulkner GC, Krajewski AS, Crawford DH (2000) The ins and outs of EBV infection. Trends Microbiol 8: 185-189
9. Hanto DW, Gajl-Peczalska KJ, Frizzera G et al. (1983) Epstein-Barr virus (EBV) induced polyclonal and monoclonal B-cell lymphoproliferative diseases occurring after renal transplantation. Clinical, pathologic, and virologic findings and implications for therapy. Ann Surg 198: 356-369
10. Jaffe ES, Harris NL, Stein H, Vardlman JW (2001) Pathology and genetics of tumors of haematopoietic and lymphoid tissues. IARC Press, Lyon
11. Keogh PV, Fisher V, Flint SR (2002) Resolution of oral non-Hodgkin's lymphoma by reduction of immunosuppressive therapy in a renal allograft recipient: A case report and review of the literature. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 94: 697-701
12. Leong IT, Fernandes BJ, Mock D (2001) Epstein-Barr virus detection in non-Hodgkin's lymphoma of the oral cavity: An immunocytochemical and in situ hybridization study. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 92: 184-193
13. Mealey BL, Tunder GS, Pemble CW 3rd (2002) Primary extranodal malignant lymphoma affecting the periodontium. J Periodontol 73: 937-941
14. Melms A, Hohfeld R, Gold R et al. (2003) Leitlinien für Diagnostik und Therapie in der Neurologie. Thieme, Stuttgart
15. Müller AM, Ihorst G, Mertelsmann R, Engelhardt M (2005) Epidemiology of non-Hodgkin's lymphoma (NHL): Trends, geographic distribution, and etiology. Ann Hematol 84: 1-12
16. Oertel SH, Riess H (2002) Immunosurveillance, immunodeficiency and lymphoproliferations. Recent Results Cancer Res 159: 1-8
17. Oertel SH, Riess H (2002) Antiviral treatment of Epstein-Barr virus-associated lymphoproliferations. Recent Results Cancer Res 159: 89-95
18. Parrington SJ, Punnia-Moorthy A (1999) Primary non-Hodgkin's lymphoma of the mandible presenting following tooth extraction. Br Dent J 187: 468-470
19. Patel P, Moazzam N, Potti A, Mehdi SA (2005) Azathioprine induced Hodgkin lymphoma: A case report and review of literature. Am J Clin Oncol 28: 427-428
20. Preiß JC, Dornoff W, Hagmann F-G, Schmieder A (2004) Onkologie 2004/05. Interdisziplinäre Empfehlungen zur Therapie, 12. Aufl. Zuckschwert, München
21. Raut A, Huryn J, Pollack A, Zlotolow I (2000) Unusual gingival presentation of post-transplantation lymphoproliferative disorder: A case report and review of the literature. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 90: 436-441
22. Shindoh M, Takami T, Arisue M et al. (1997) Comparison between submucosal (extra-nodal) and nodal non-Hodgkin's lymphoma (NHL) in the oral and maxillofacial region. J Oral Pathol Med 26: 283-289
23. Toyka KV (2003) Therapeutischer Stellenwert von Azathioprin bei der Behandlung der Myasthenia gravis. Akt Neurol 30: 1-2
24. Zeeb H, Blettner M (2001) Steigende Inzidenz und Mortalität der Non-Hodgkin-Lymphome - eine epidemiologische Übersicht über neuere Studien zu Risikofaktoren des Non-Hodgkin-Lymphoms. Med Klin (Munich) 96: 87-100